semaglutide and nonarteritic anterior ischemic optic neuropathy linked to increased risk of vision loss in diabetes patients nonarteritic anterior ischemic optic neuropathy

It's important that if I'm going to lose muscle, I need to have some protein

Note: Patients without diabetes were judged to have progressed to type 2 diabetes if two or more consecutive measurements showed fasting glucose concentrations of at least 6.99 mmol/L or the oral glucose tolerance test after 2 h was at least 11.1 mmol/L

Prioritizing protein intake preserves this metabolic advantage and produces better long-term outcomes

Timing depends on individual dose, duration of use, and planned pregnancy onset, requiring coordinated provider guidance

MASLD treatments targeting the enterohepatic axis and gut microbiota are gradually emerging, and a variety of new metabolism-modulating drugs are also under clinical development